ACtero
Academy
TONE
How we talk to
Health Care Professional
FORMAL
DIRECT
TECHNICAL
PRECISE
The Lancet Oncology
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (Gepa1)
Gunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens U Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Dirk M Zahm, Sherko Kümmel, Holger Eidtmann, Peter Klare, Jens Huober, Serban Costa, Hans Tesch, Claus Hanusch, Jörn Hilfrich, Fariba Khandan, Peter A Fasching, Bruno V Sinn, Knut Engels, Keyur Mehta, Valentina Nekljudova, Michael Untch
DOWNLOAD
Critical Reviews in Oncology / Hematology
Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis
Rui Pedro Marquesa,b,⁎, Gonçalo S. Duartec,d,e, Carmelo Sterrantinof,g, Helena Luna Paisb, António Quintelab, Ana Paula Martinsa, João Costac,d,e
DOWNLOAD
the Oncologist
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis
FILIPPO PIETRANTONIO,a,b,† GIOVANNI FUCÀ ,a,† DANIELE ROSSINI,c,d HANS-JOACHIM SCHMOLL,e JOHANNA C. BENDELL,f FEDERICA MORANO,a CARLOTTA ANTONIOTTI,c,d SALVATORE CORALLO,a BEATRICE BORELLI,c,d ALESSANDRA RAIMONDI,a FEDERICA MARMORINO,c,d MONICA NIGER,a ALESSANDRA BOCCACCINO,c,d GIANLUCA MASI,c,d SARA LONARDI,g LUCA BONI,h FILIPPO DE BRAUD,a,b MARIA DI BARTOLOMEO,a ALFREDO FALCONE,c,d CHIARA CREMOLINIc,d
DOWNLOAD
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens U Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Dirk M Zahm, Sherko Kümmel, Holger Eidtmann, Peter Klare, Jens Huober, Serban Costa, Hans Tesch, Claus Hanusch, Jörn Hilfrich, Fariba Khandan, Peter A Fasching, Bruno V Sinn, Knut Engels, Keyur Mehta, Valentina Nekljudova, Michael Untch
DOWNLOAD
The new england journal of medicine
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
N.D. James, J.S. de Bono, M.R. Spears, N.W. Clarke, M.D. Mason, D.P. Dearnaley, A.W.S. Ritchie, C.L. Amos, C. Gilson, R.J. Jones, D. Matheson, R. Millman, G. Attard, S. Chowdhury, W.R. Cross, S. Gillessen, C.C. Parker, J.M. Russell, D.R. Berthold, C. Brawley, F. Adab, S. Aung, A.J. Birtle, J. Bowen, S. Brock, P. Chakraborti, C. Ferguson, J. Gale, E. Gray, M. Hingorani, P.J. Hoskin, J.F. Lester, Z.I. Malik, F. McKinna, N. McPhail, J. Money‑Kyrle, J. O’Sullivan, O. Parikh, A. Protheroe, A. Robinson, N.N. Srihari, C. Thomas, J. Wagstaff, J. Wylie, A. Zarkar, M.K.B. Parmar, and M.R. Sydes, for the STAMPEDE Investigators
DOWNLOAD
British Journal Of Center
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial
Volker Heinemann1, Ludwig Fischer von Weikersthal2, Thomas Decker3, Alexander Kiani4, Florian Kaiser5, Salah-Edin Al-Batran6, Tobias Heintges7, Christoph Lerchenmüller8, Christoph Kahl9, Gernot Seipelt10, Frank Kullmann11, Markus Moehler12, Werner Scheithauer13, Swantje Held14, Lisa Miller-Phillips1, Dominik Paul Modest1, Andreas Jung15, Thomas Kirchner15 and Sebastian Stintzing16
DOWNLOAD
Journal of B.U.ON.
Capecitabine plus temozolomide (CapTem): An alternative regimen to regorafenib as third-line setting in metastatic colorectal cancer?
Yakup Ergun, Oznur Bal, Mutlu Dogan, Dogan Uncu Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
DOWNLOAD
Nature
Bevacizumab plus capecitabine as later‑line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines
Yeong Hak Bang1,3,4, Jeong Eun Kim1,4, Ji Sung Lee2, SunYoung Kim1, Kyu‑Pyo Kim1, Tae Won Kim1 & Yong Sang Hong
DOWNLOAD
JOURNAL OF CLINICAL ONCOLOGY
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Cloughesy, Olivier L. Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, Nicola Moore, Samir Kharbanda, Franklin Peale, Priti Hegde, Lauren E. Abrey, Heidi S. Phillips, and Carlos Bais
DOWNLOAD
JOURNAL OF CLINICAL ONCOLOGY
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
Katherine S. Virgo, PhD, MBA1; R. Bryan Rumble, MSc2; Ronald de Wit, MD, PhD3; David S. Mendelson, MD4; Thomas J. Smith, MD5; Mary-Ellen Taplin, MD6; James L. Wade III, MD7; Charles L. Bennett, MD, PhD8; Howard I. Scher, MD9; Paul L. Nguyen, MD6; Martin Gleave, MD10; Scott C. Morgan, MD, MSc11; Andrew Loblaw, MD, MSc12; Sean Sachdev, MD13; David L. Graham, MD14; Neha Vapiwala, MD15; Amy M. Sion, PharmD16; Virgil H. Simons, MPA17; and James Talcott, MD, SM18
DOWNLOAD
1
2
3
4
5
Next